Quick Answer
INTEST CORP reported R&D Expense of $9.44 million for fiscal year 2025.
INTEST CORP R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $9.44M | +10.4% |
| 2024 | $8.55M | +12.2% |
| 2023 | $7.62M | +1.2% |
| 2022 | $7.53M | +36.1% |
| 2021 | $5.53M | +9.1% |
| 2020 | $5.07M | +2.1% |
| 2019 | $4.96M | +1.1% |
| 2018 | $4.91M | +14.1% |
| 2017 | $4.30M | +17.5% |
| 2016 | $3.66M | -7.0% |
| 2015 | $3.94M | +9.9% |
| 2014 | $3.58M | -2.8% |
| 2013 | $3.68M | -5.4% |
| 2012 | $3.90M | +20.2% |
| 2011 | $3.24M | +6.4% |
| 2010 | $3.04M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.33M | +7.0% | +4.0% |
| June 30, 2025 | $2.25M | +1.2% | -8.3% |
| March 31, 2025 | $2.45M | +23.5% | +12.2% |
| September 30, 2024 | $2.18M | +21.1% | -1.6% |
| June 30, 2024 | $2.22M | +11.9% | +11.9% |
| March 31, 2024 | $1.98M | +4.1% | +10.0% |
| September 30, 2023 | $1.80M | -3.4% | -9.1% |
| June 30, 2023 | $1.98M | +6.7% | +4.1% |
- INTEST CORP showed an increase of +10.4% in R&D Expense compared to the prior fiscal year.
- Over the 2010–2025 period, INTEST CORP’s r&d expense has grown by 210.1% (from $3.04 million to $9.44 million).
- The most recent figure is from INTEST CORP’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 12, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: